Suppr超能文献

导管原位癌(DCIS)既往诊断对浸润性乳腺癌生存的影响。

Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.

作者信息

Sopik Victoria, Iqbal Javaid, Sun Ping, Narod Steven A

机构信息

Women's College Research Institute, 76 Grenville Street, Toronto, ON, M5S 1B1, Canada.

Institute of Medical Science, University of Toronto, Toronto, Canada.

出版信息

Breast Cancer Res Treat. 2016 Jul;158(2):385-93. doi: 10.1007/s10549-016-3894-9. Epub 2016 Jul 6.

Abstract

A diagnosis of invasive breast cancer after DCIS can be described as a new primary cancer or as a local invasive recurrence. It is of interest to determine if, among women with early-stage breast cancer, a past history of DCIS influences survival. We retrieved the records of 306,249 women diagnosed with stage I or stage II breast cancer between 2004 and 2012, in the surveillance, epidemiology, and end results registries database, of whom 5395 had a previous diagnosis of DCIS. For each patient, we extracted information on the year of diagnosis, age at diagnosis, tumor size, nodal status, grade, estrogen receptor status, type of surgery (lumpectomy/mastectomy), use of radiotherapy (no/yes), prior DCIS (no/yes), cause of death, and follow-up time. For each case with prior DCIS, we recorded information on the year of diagnosis of DCIS, laterality of DCIS, and treatments received for DCIS. We matched 3979 patients with a prior DCIS to 3979 patients without a prior DCIS, according to the various prognostic features of the invasive cancer. We estimated the risk of death from breast cancer for patients with invasive ductal carcinoma, with and without a prior diagnosis of DCIS. We identified 306,249 women with stage I/II breast cancer, of whom 2335 had a prior ipsilateral DCIS and 3060 had a prior contralateral DCIS. Breast cancer-specific survival at 9 years was 94.6 % for patients with a prior DCIS (ipsilateral or contralateral) and was 95.2 % for patients with no prior DCIS (p = 0.32). In a matched analysis (3979 matched pairs), the hazard ratio for death from breast cancer for patients with a prior ipsilateral DCIS, compared to patients with no prior DCIS, was 0.91 (95 % CI = 0.49-1.68; p = 0.75). A prior diagnosis of ipsilateral DCIS does not impact upon the prognosis of women with early-stage invasive breast cancer. This suggests that primary breast cancers and local invasive recurrences following DCIS are similar conditions and should be treated in the same way.

摘要

导管原位癌(DCIS)后诊断为浸润性乳腺癌可描述为新发原发性癌症或局部浸润性复发。确定在早期乳腺癌女性中,既往DCIS病史是否影响生存很有意义。我们在监测、流行病学和最终结果登记数据库中检索了2004年至2012年间诊断为I期或II期乳腺癌的306,249名女性的记录,其中5395人既往诊断为DCIS。对于每位患者,我们提取了诊断年份、诊断时年龄、肿瘤大小、淋巴结状态、分级、雌激素受体状态、手术类型(保乳手术/乳房切除术)、放疗使用情况(否/是)、既往DCIS(否/是)、死亡原因和随访时间等信息。对于每例有既往DCIS的病例,我们记录了DCIS诊断年份、DCIS的患侧以及DCIS接受的治疗。根据浸润性癌症的各种预后特征,我们将3979例有既往DCIS的患者与3979例无既往DCIS的患者进行匹配。我们估计了有和无既往DCIS诊断的浸润性导管癌患者死于乳腺癌的风险。我们确定了306,249例I/II期乳腺癌女性,其中2335人有既往同侧DCIS,3060人有既往对侧DCIS。有既往DCIS(同侧或对侧)的患者9年乳腺癌特异性生存率为94.6%,无既往DCIS的患者为95.2%(p = 0.32)。在匹配分析(3979对匹配)中,有既往同侧DCIS的患者与无既往DCIS的患者相比,死于乳腺癌的风险比为0.91(95%CI = 0.49 - 1.68;p = 0.75)。既往同侧DCIS诊断不影响早期浸润性乳腺癌女性的预后。这表明原发性乳腺癌和DCIS后的局部浸润性复发是相似情况,应采用相同的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验